Morphic Therapeutic: Funding, Investors & Team (Sep 2026)
Morphic Therapeutic is in the process of creating a new type of integrin therapies that can be taken orally, and is a biotechnology corporation.
Morphic Therapeutic has raised $100M across 1 funding round on record, the most recent an undisclosed round of $100M announced in Mar 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Morphic Therapeutic Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Morphic Therapeutic Funding Rounds
Morphic Therapeutic Founders and Leadership Team
Contact details for the Morphic Therapeutic team: 1 of 1 has an email address on file.
Start 14-day free trial →Morphic Therapeutic Funding Compared to Other Biotechnology Startups
Morphic Therapeutic's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Morphic Therapeutic in Biotechnology and Waltham
Companies Similar to Morphic Therapeutic
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Morphic Therapeutic Funding FAQs
What does Morphic Therapeutic do?
Morphic Therapeutic is in the process of creating a new type of integrin therapies that can be taken orally, and is a biotechnology corporation.
How much funding has Morphic Therapeutic raised?
Morphic Therapeutic has raised $100M across 1 round on record. The most recent is an undisclosed round of $100M announced in Mar 2023.
When did Morphic Therapeutic last raise funding?
Morphic Therapeutic's most recent funding round on record is an undisclosed round of $100M, announced in Mar 2023.
Who is the CEO of Morphic Therapeutic?
Praveen Tipirneni is listed as CEO at Morphic Therapeutic.
Where is Morphic Therapeutic headquartered?
Morphic Therapeutic is based in Waltham, Massachusetts, United States.
How many employees does Morphic Therapeutic have?
Morphic Therapeutic is in the 101-250 employee band.
How does Morphic Therapeutic's funding compare to other Biotechnology startups?
Morphic Therapeutic's latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Morphic Therapeutic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Morphic Therapeutic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.